methyldopa has been researched along with Birth Weight in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (66.67) | 18.7374 |
1990's | 4 (19.05) | 18.2507 |
2000's | 1 (4.76) | 29.6817 |
2010's | 1 (4.76) | 24.3611 |
2020's | 1 (4.76) | 2.80 |
Authors | Studies |
---|---|
Avalos, LA; Badon, SE; Bider-Canfield, Z; Cheetham, TC; Chen, L; Dublin, S; Easterling, TR; Holt, VL; Idu, A; Nance, N; Neugebauer, RS; Reynolds, K; Shortreed, SM | 1 |
Attalla, SM; Elmansoury, AM; Gouda, HE; Harouny, MA; Motawei, SM | 1 |
Adam, I; Elhassan, EM; Habour, AB; Mirghani, OA | 1 |
Hockings, NF | 1 |
Fuerst, M | 1 |
Sandström, B | 1 |
De Swiet, M; Fayers, P; Fidler, J; Smith, V | 1 |
Morrissey, JR; Williams, ER | 1 |
Crenshaw, MC; Dorminy, JH; Gall, SA; Jelovsek, FR; Welt, SI | 1 |
Clairambault, J; Curzi-Dascalova, L; Eiselt, M; Kauffmann, F; Médigue, C; Peirano, P; Spassov, L | 1 |
Gee, H; Oláh, KS; Redman, CW | 1 |
Redman, CW | 1 |
Gallery, ED; Györy, AZ; Hunyor, SN; Saunders, DM | 1 |
Blake, S; MacDonald, D | 1 |
De Andrade, J | 1 |
Aber, VR; De Vries, LS; Derham, RJ; Elder, MG; Hawkins, DF | 1 |
Gallery, ED; Gyory, AZ; Ross, MR | 1 |
Abdella, TN; Anderson, GD; Brooks, TF; Sibai, BM; Spinnato, JA; Taslimi, M | 1 |
Cockburn, JM; Moar, VA; Ounsted, MK; Redman, CW | 1 |
Baker, P; Chadd, MA; Humphreys, DM; Leather, HM | 1 |
Baker, PA; Chadd, MA; Humphreys, DM; Leather, HM | 1 |
10 trial(s) available for methyldopa and Birth Weight
Article | Year |
---|---|
Methyldopa versus no drug treatment in the management of mild pre-eclampsia.
Topics: Abruptio Placentae; Adult; Antihypertensive Agents; Apgar Score; Birth Weight; Delivery, Obstetric; Disease Progression; Eclampsia; Female; Fetal Death; Fetal Growth Retardation; Humans; Methyldopa; Organ Size; Parity; Pediatrics; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, Third; Referral and Consultation; Severity of Illness Index; Treatment Outcome | 2002 |
Beta-blockers may have role in preeclampsia.
Topics: Adrenergic beta-Antagonists; Atenolol; Birth Weight; Clinical Trials as Topic; Female; Humans; Hypertension; Infant, Newborn; Methyldopa; Pre-Eclampsia; Pregnancy; Propranolol | 1982 |
Randomised controlled comparative study of methyldopa and oxprenolol in treatment of hypertension in pregnancy.
Topics: Adult; Birth Weight; Clinical Trials as Topic; Female; Gestational Age; Humans; Hypertension; Methyldopa; Oxprenolol; Pregnancy; Pregnancy Complications, Cardiovascular; Random Allocation | 1983 |
The effects of prophylactic management and therapeutics on hypertensive disease in pregnancy: preliminary studies.
Topics: Adult; Antihypertensive Agents; Birth Weight; Blood Pressure; Body Weight; Female; Humans; Hydralazine; Hypertension; Infant, Newborn; Methyldopa; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Random Allocation | 1981 |
Fetal outcome in trial of antihypertensive treatment in pregnancy.
Topics: Abortion, Spontaneous; Adult; Birth Weight; Clinical Trials as Topic; Drug Evaluation; Female; Fetal Death; Fetus; Follow-Up Studies; Growth; Humans; Hypertension; Infant, Newborn; Infant, Newborn, Diseases; Methyldopa; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, Second | 1976 |
Randomised comparison of methyldopa and oxprenolol for treatment of hypertension in pregnancy.
Topics: Adult; Birth Weight; Blood Glucose; Creatinine; Female; Humans; Hypertension; Methyldopa; Oxprenolol; Plasma Volume; Pregnancy; Pregnancy Complications, Cardiovascular; Random Allocation; Uric Acid | 1979 |
The prevention of the maternal manifestations of pre-eclampsia by intensive antihypertensive treatment.
Topics: Adult; Atenolol; Bendroflumethiazide; Birth Weight; Drug Therapy, Combination; Embryonic and Fetal Development; Female; Fetal Death; Humans; Hypertension; Infant, Newborn; Methyldopa; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Proteinuria | 1991 |
Antihypertensive treatment in pregnancy: analysis of different responses to oxprenolol and methyldopa.
Topics: Adult; Birth Weight; Clinical Trials as Topic; Female; Humans; Hydralazine; Hypertension; Infant, Newborn; Male; Methyldopa; Oxprenolol; Pregnancy; Pregnancy Complications, Cardiovascular; Random Allocation | 1985 |
A controlled trial of hypotensive agents in hypertension in pregnancy.
Topics: Abortion, Spontaneous; Antihypertensive Agents; Bendroflumethiazide; Birth Weight; Creatinine; Female; Humans; Infant Mortality; Infant, Newborn; Kidney Function Tests; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular; Prognosis; Proteinuria; Time Factors | 1968 |
Controlled trial of hypotensive agents in hypertension in pregnancy.
Topics: Bendroflumethiazide; Birth Weight; Clinical Trials as Topic; Female; Fetal Death; Humans; Hypertension; Kidney Function Tests; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular | 1968 |
11 other study(ies) available for methyldopa and Birth Weight
Article | Year |
---|---|
Maternal and neonatal outcomes of antihypertensive treatment in pregnancy: A retrospective cohort study.
Topics: Antihypertensive Agents; Birth Weight; Female; Humans; Hypertension, Pregnancy-Induced; Infant; Infant, Newborn; Infant, Newborn, Diseases; Labetalol; Methyldopa; Nifedipine; Pregnancy; Pregnancy Outcome; Premature Birth; Retrospective Studies | 2022 |
The effects of N-acetyl cysteine on oxidative stress among patients with pre-eclampsia.
Topics: Acetylcysteine; Antihypertensive Agents; Apgar Score; Birth Weight; Drug Therapy, Combination; Female; Free Radical Scavengers; Humans; Infant, Newborn; Methyldopa; Oxidative Stress; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Treatment Outcome | 2016 |
Safety, for the child, of drug treatment for hypertension in pregnancy.
Topics: Antihypertensive Agents; Birth Weight; Female; Fetus; Humans; Hypertension; Infant, Newborn; Male; Maternal-Fetal Exchange; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular | 1982 |
Clinical trials of adrenergic antagonists in pregnancy hypertension.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Apgar Score; Birth Weight; Female; Fetal Growth Retardation; Humans; Hydralazine; Hypertension; Infant, Newborn; Methyldopa; Metoprolol; Oxprenolol; Pregnancy; Pregnancy Complications, Cardiovascular; Respiratory Distress Syndrome, Newborn | 1984 |
A comparison of acebutolol with methyldopa in hypertensive pregnancy.
Topics: Acebutolol; Adult; Apgar Score; Birth Weight; Blood Pressure; Female; Humans; Hypertension; Infant, Newborn; Length of Stay; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies | 1983 |
Heart rate and heart rate variability during sleep in small-for-gestational age newborns.
Topics: Basal Metabolism; Birth Weight; Female; Fetal Growth Retardation; Gestational Age; Heart Rate; Humans; Hypertension; Infant, Newborn; Infant, Small for Gestational Age; Labetalol; Male; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular; Sleep | 1994 |
Management of severe, early pre-eclampsia: is conservative management justified?
Topics: Birth Weight; Blood Pressure; Dexamethasone; Female; Humans; Hypertension; Infant Mortality; Infant, Newborn; Intensive Care, Neonatal; Methyldopa; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Proteinuria; Retrospective Studies; Uric Acid | 1993 |
[Use of alphamethyldopa during the pregnancy-puerperium cycle in hypertensive patients and evaluation of their offspring up to their 3rd year of life].
Topics: Adult; Birth Weight; Blood Pressure; Child, Preschool; Female; Humans; Hypertension; Infant; Infant, Newborn; Male; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Puerperal Disorders | 1990 |
Outcome of pregnancies complicated by severe hypertension and delivered before 34 weeks; stepwise logistic regression analysis of prognostic factors.
Topics: Adult; Birth Weight; Cerebral Hemorrhage; Cesarean Section; Female; Fetal Growth Retardation; Gestational Age; Humans; Hydralazine; Hypertension; Infant, Newborn; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Prognosis; Proteinuria; Puerperal Disorders; Regression Analysis | 1989 |
Maternal and perinatal outcome of conservative management of severe preeclampsia in midtrimester.
Topics: Administration, Oral; Antihypertensive Agents; Bed Rest; Birth Weight; Delivery, Obstetric; Diuretics; Female; Fetal Death; Gestational Age; Humans; Hydralazine; Infant, Newborn; Magnesium Sulfate; Methyldopa; Outcome and Process Assessment, Health Care; Phenobarbital; Pre-Eclampsia; Pregnancy; Pregnancy Trimester, Second; Pregnancy, Prolonged; Retrospective Studies | 1985 |
Factors associated with the blood pressures of children born to women who were hypertensive during pregnancy.
Topics: Birth Weight; Blood Pressure; Body Weight; Child; Diastole; Female; Humans; Hypertension; Male; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Systole | 1985 |